- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01409785
A Comparison of the LMA Unique and LMA Supreme in Children
A Prospective, Randomized Comparison of the LMA Unique and LMA Supreme in Children
Study Overview
Status
Conditions
Detailed Description
The LMA Supreme is a newer version of the current model, the laryngeal mask airway Unique. Both models are approved for use by the FDA, and are routinely used for airway management during general anesthesia. Three main features distinguish the laryngeal mask airway Supreme from the original LMA: i) a curved rigid airway tube, ii) provision for a gastric drain tube, and iii) a larger mask for improved fit and airway seal.
The aim of this randomized prospective study is to compare two types of the laryngeal mask airway: the laryngeal mask airway Unique and the laryngeal mask airway Supreme, in pediatric patients without the use of neuromuscular blockade. Based on the design features listed above, we hypothesize that the airway leak pressures with the LMA Supreme will be superior to the LMA Unique. Airway leak pressures will be measured by recording the circuit pressure at which equilibrium is reached. The ease of placement, fiberoptic grade of laryngeal view, feasibility of use, and complications (airway related, gastric insufflation, trauma) will also be assessed.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60614
- Childrens Memorial Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Children undergoing general anesthesia using a supraglottic airway device
- weight 10-25kg
- age 6 months-6 years
Exclusion Criteria:
ASA class IV, V Emergency procedures
- History of a difficult airway
- Active gastrointestinal reflux
- Active upper respiratory tract infection
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
|---|
|
LMA Supreme
|
|
LMA unique
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Airway leak pressure
Time Frame: after placement of the supraglottic airway device/ Participants will be followed 24 hours postoperatively
|
Airway leak pressures will be measured by recording the circuit pressure at which equilibrium is reached when fresh gas flow is delivered at 3L/min when the pressure limiting valve is closed completely.
|
after placement of the supraglottic airway device/ Participants will be followed 24 hours postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fiberoptic grade of laryngeal view
Time Frame: After placement of the supraglottic device
|
The laryngeal alignment through the devices will be graded using an established scoring system
|
After placement of the supraglottic device
|
|
Adverse effects
Time Frame: Participants will be followed 24 hours postoperatively
|
complications such as oxygen desaturations, mucosal trauma, reflex activation of the airway, sore throat, dysphonia will be recorded
|
Participants will be followed 24 hours postoperatively
|
|
Time to secure the airway
Time Frame: after placement of the supraglottic airway device
|
From picking up the airway device to bilateral chest expansion and presence of ETCO2
|
after placement of the supraglottic airway device
|
|
Number of attempts to place the device
Time Frame: at the beginning of anesthesia
|
number of attempts needed for successful placement will be recorde (maximum of 3 attempts will be considered as a failure)
|
at the beginning of anesthesia
|
|
Fiberoptic view through the gastric tube
Time Frame: After placement of the LMA supreme
|
The view through the gastric drain tube of the LMA supreme will be assessed and graded using an established scoring system
|
After placement of the LMA supreme
|
|
Ease of gastric tube placement
Time Frame: After placement of the LMA supreme
|
The ease of gastric placement will be assessed using a subjective scale
|
After placement of the LMA supreme
|
|
Gastric insufflation
Time Frame: During leak pressure testing
|
The presence of gastric insufflations will be assessed during leak pressure testing by using epigastric auscultation
|
During leak pressure testing
|
|
Quality of the airway
Time Frame: During maintenance of anesthesia
|
The quality of hands free anesthesia will be assessed during maintenance of anesthesia using a previously described scale
|
During maintenance of anesthesia
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Verghese C, Ramaswamy B. LMA-Supreme--a new single-use LMA with gastric access: a report on its clinical efficacy. Br J Anaesth. 2008 Sep;101(3):405-10. doi: 10.1093/bja/aen174. Epub 2008 Jun 17.
- Timmermann A, Cremer S, Eich C, Kazmaier S, Brauer A, Graf BM, Russo SG. Prospective clinical and fiberoptic evaluation of the Supreme laryngeal mask airway. Anesthesiology. 2009 Feb;110(2):262-5. doi: 10.1097/ALN.0b013e3181942c4d.
- Cook TM, Gatward JJ, Handel J, Hardy R, Thompson C, Srivastava R, Clarke PA. Evaluation of the LMA Supreme in 100 non-paralysed patients. Anaesthesia. 2009 May;64(5):555-62. doi: 10.1111/j.1365-2044.2008.05824.x.
- White MC, Cook TM, Stoddart PA. A critique of elective pediatric supraglottic airway devices. Paediatr Anaesth. 2009 Jul;19 Suppl 1:55-65. doi: 10.1111/j.1460-9592.2009.02997.x.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- LMA unique vs LMA supreme
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Children
-
Duke UniversityBoston Children's Hospital; Agency for Healthcare Research and Quality (AHRQ)CompletedChildren, Only | Children and Youth With Special Healthcare NeedsUnited States
-
Elizabeth Glaser Pediatric AIDS FoundationUnited States Agency for International Development (USAID); Biomedical Research... and other collaboratorsTerminatedOrphans, Children, Adolescents | Vulnerable Children, Adolescents | Community-basedZimbabwe
-
National Institute of Mental Health (NIMH)RecruitingHealthy Children | Children With Neurodevelopmental Disorders | Children With Neuropsychiatric Disorders | Children With Behavioral SyndromesUnited States
-
Centre Hospitalier St AnneCentre National de la Recherche Scientifique, France; Université Paris CitéNot yet recruitingChildren | Typical Development | FRENCH STUDY | Children Behavior Problem | Typical Preschoolers Who Can Not Zipper | Typically Developing Children Ages 3 to 6
-
University of PaviaNot yet recruiting
-
Georgetown UniversityPenn State UniversityCompleted
-
Sheffield Children's NHS Foundation TrustUniversity of Sheffield; Sheffield Hallam UniversityCompletedChildrenUnited Kingdom
-
Ann & Robert H Lurie Children's Hospital of ChicagoCompleted
-
Ann & Robert H Lurie Children's Hospital of ChicagoCompletedChildrenUnited States